Ron Priefer is an experienced Professor with a demonstrated history of working in the higher education industry. He is a strong education professional skilled in NMR Spectroscopy, Materials Science, Liquid Chromatography-Mass Spectrometry (LC-MS), Research Design, and Polymers. In his current role as a Professor of Medicinal Chemistry and the Graduate Program Director, Ron focuses his research on Alzheimer's Diabetes, and Cancer. Ron also leads Breath Health as its co-Founder and CEO, and the company is developing a technology that specifically detects breath acetone using a nanotechnology approach.
Industry Expertise (1)
Areas of Expertise (8)
McGill University: Ph.D., Organic Chemistry 2003
Selected Articles (4)
Evaluation of current post-concussion protocolsBiomedicine & Pharmacotherapy
2020 The growing number of concussions and mild traumatic brain injuries (mTBI) with the lack of evidence-based treatment options is a continuous health concern. This creates problems when evaluating and providing efficacious symptom management to patients suffering from post-concussion syndrome (PCS). Numerous pharmacological and non-pharmacological agents have been utilized in an attempt to treat PCS.
Non-Porphyrin Dyes Used as Photosensitizers in Photodynamic TherapyJournal of Drug Delivery Science and Technology
2020 Photodynamic therapy (PDT) is the process of applying a light source onto a photosensitive chemical in order to produce reactive oxygen species. This process has gained prevalence within the oncology space as a potential treatment strategy, as PDT allows for accumulation of the photosensitive chemical at the site of the malignancy; therefore, when the reactive oxygen species are formed, they can to be cytotoxic towards the malignant cells.
THC Detection in the BreathTalanta
2020 Cannabis legalization and common use has further driven the need for accurate THC detection and analysis for roadside testing. While reliable and accurate techniques, such as mass spectrometry (MS) exist for the analysis of THC, the market lacks technologies that are portable and can be utilized outside of a laboratory setting. Innovations utilizing unique technologies have steadily been increasing.
The Silent Development of Counterfeit Medications in Developing Countries – A Systematic Review of Detection TechnologiesInternational Journal of Pharmaceutics
2020 Drug counterfeiting detection is very important for the safety of patients around the world. Counterfeit pharmaceutical products can be referred to the production and distribution of mislabeled medications in which the identity, authenticity, and/or effectiveness is altered. Drugs are often counterfeited to reduce manufacture costs, while still marketing it at as an authentic product. Increased incidence of drug counterfeiting is most noticeable in developing countries, which may not have the resources to supply counterfeit detection devices at a large scale.